Canopy Growth Corp: The Bottom Isn’t In

Canopy Growth Corp (TSX:WEED) is hitting new lows. Unfortunately, the bottom probably isn’t in.

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

Canopy Growth (TSX:WEED) stock has performed extremely badly since cannabis was legalized in October 2018. Almost from that exact date, the stock began a precipitous downfall that continues to this very day. So far this year, WEED stock has declined 59% in value, following several years of similar results. Since the stock hit its peak in October of 2018, it has declined 98% in price! At one point, the stock was well into “penny stock” territory, trading for as little as 50 cents.

Naturally, this got some investors smelling a bargain, as the stock had declined so much that it was beginning to look absurdly cheap. However, as you’ll soon see, Canopy’s valuation is nowhere near as “absurd” as it seems — and it may even be justified. For this reason, I think it’s possible that the bottom in WEED shares isn’t even in. I’ll spend the next few paragraphs explaining why I believe that to be the case.

Revenue declines

One big problem Canopy Growth is having right now is its long-term decline in revenue. Over the last five years, the company’s revenue has declined by about 1.05% per year. This is partially due to underperforming subsidiaries having been sold off, but the problem is the company’s earnings are declining even faster than its revenue is. In that same five-year period, the per-share loss grew from -$0.38 to -$2.45. Therefore, Canopy is having trouble with costs as well as revenue.

Why Canopy Growth is shrinking

There are three main reasons why Canopy Growth Corp is a shrinking business:

  1. Money from the Constellation Brands deal is running out.
  2. Cannabis is a commodity.
  3. Cannabis still faces pressure from the black market.

A few months before legalization hit, Canopy Growth got a $5 billion investment from Constellation Brands. The cash infusion was supposed to be used on growth spending, but as the section above demonstrates, Canopy has shrunk rather than grown. In other words, the cash from STZ is running out, and Canopy has little to show for it.

Second, cannabis is a commodity. Canadian cannabis consumers don’t have very high brand loyalty. Despite the efforts to market different cannabis “strains,” most consumers see them as interchangeable. On top of that, the black market for cannabis still exists and is even thriving in some areas. So, Canopy faces a lot of competition, not just from other cannabis companies but from old-school street dealers as well.

Hope for a better future?

Despite all of the negative things I wrote above, there are some reasons to be optimistic toward Canopy Growth stock. For one thing, all other cannabis companies are in the same boat of declining revenue and large losses. If this situation continues, eventually, some of them will go bankrupt, and the ones left standing will face less competition. The result should be more pricing power and better margins. There’s reason to hope for the sector as a whole, but who knows whether Canopy itself will be the stock to own in a future, more concentrated cannabis industry. Personally, I’m sitting this round out.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned. The Motley Fool recommends Constellation Brands. The Motley Fool has a disclosure policy.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »